home / press / releases

Menu
  • Search all tables

releases: http://www.enzi.senate.gov//public/index.cfm/news-releases?ContentRecord_id=9FB0D674-269D-43AB-B680-3084D1C3D21B

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
http://www.enzi.senate.gov//public/index.cfm/news-releases?ContentRecord_id=9FB0D674-269D-43AB-B680-3084D1C3D21B Enzi, Hassan introduce bill to protect against counterfeit medical products 2020-07-20 2020 2020-07 Republican House WY Michael Enzi E000285 www.enzi.senate.gov     legacy U.S. Senators Mike Enzi, R-Wyo., and Maggie Hassan, D-N.H., introduced legislation that would help protect patients from counterfeit medical products that could cause serious harm. The Safeguarding Therapeutics Act would give the Food and Drug Administration (FDA) authority to seize and destroy counterfeit medical devices and products, including vaccines and combination products like EpiPens. It is a Senate companion to legislation introduced by Representatives Brett Guthrie, R-Ky., and Eliot Engel, D-N.Y., which is included in the latest coronavirus relief package passed by the House. As we continue to combat the coronavirus pandemic, it is critical to ensure that vaccines, COVID-19 tests and other medical products are safe and reliable, Enzi said. This bill would allow the FDA to destroy counterfeit medical products that could be dangerous to patients while strengthening our health care supply chain at a time when we need it most. Amid the COVID-19 pandemic, ensuring that people have access to safe and effective medical products is more essential than ever, Hassan said. This bipartisan legislation to allow the FDA to destroy counterfeit medical products will protect public health and keep the American people safe. This legislation builds on the 2012 Food and Drug Administration Safety and Innovation Act, which gave the FDA the ability to seize and destroy counterfeit drugs, but not medical devices. 1 2026-03-30T12:14:52Z 2026-03-30T12:14:52Z
Powered by Datasette · Queries took 1.076ms · Data license: MIT · Data source: dwillis/congress-press